About Becton, Dickinson & Co. 
Becton, Dickinson & Co.
Pharmaceuticals & Biotechnology
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
Company Coordinates 
Company Details
1 Becton Dr , FRANKLIN LAKES NJ : 07417-1815
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 191 Schemes (36.78%)
Foreign Institutions
Held by 516 Foreign Institutions (26.87%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Vincent Forlenza
Executive Chairman of the Board
Mr. Thomas Polen
President, Chief Executive Officer, Chief Operating Officer, Director
Mr. Marshall Larsen
Lead Independent Director
Ms. Catherine Burzik
Independent Director
Mr. R. Andrew Eckert
Independent Director
Ms. Claire Fraser
Independent Director
Mr. Jeffrey Henderson
Independent Director
Revenue and Profits:
Net Sales:
5,509 Million
(Quarterly Results - Jun 2025)
Net Profit:
574 Million
Pharmaceuticals & Biotechnology
USD 70,270 Million (Large Cap)
33.00
NA
2.53%
0.73
7.79%
2.76






